Chief Scientific Officer
Dr. Paul Dempsey is an immunologist with more than 20 years of experience in biomedical research and analysis. Before joining Cynvenio, Dr. Dempsey was an assistant research professor in the department of microbiology, immunology and molecular genetics at the University of California, Los Angeles. He brings extensive hands-on research experience in life sciences, molecular biology and reagent development.
Dr. Dempsey was a Leukemia and Lymphoma Society Fellow from 2000 to 2003, has published 20 scientific articles and abstracts, and holds two patents in technologies designed to amplify the immunogenicity of vaccines.
Dr. Dempsey holds a B.S. in microbiology and virology from the University of Warwick in Coventry, U.K. and a Ph.D. from Johns Hopkins University School of Medicine.